Activity Dates: 11/07/2018 - 05/07/2019
This self-study activity serves as an educational tool for pharmacists seeking Board Certified Psychiatric Pharmacist (BCPP) Recertification credit and other pharmacists and healthcare providers seeking advanced education in patient and disease state management in the field of psychiatric pharmacy.
This recertification product consists of four clinical review articles focused on single disorders, or on one or more distinct aspects of a single psychiatric, neurologic, or substance use disorder. Authored by leading experts in the field and hosted in CPNP’s peer-reviewed journal, The Mental Health Clinician (MHC), these case-based articles will be full referenced and offer therapeutic advice based on both evidence and longstanding clinical experience. Pearls articles focus on aspects of disease states and their pharmacotherapy that require synthesis of solutions to problems or development of practices that require judgement(s) founded on evidence, but modified or tempered by extensive clinical experience and practicalities of “real world” necessities. The articles are intended to allow you to gain greater insights into the strategies of clinical decision-making used by expert clinicians.
Psychopharmacology Pearls is an application-based continuing pharmacy education (CPE) activity that releases on November 7, 2018. An application-based CPE activity requires that participants apply the information learned. The examination for this product often features case studies requiring that the participant apply the principles learned through the readings. Psychopharmacology Pearls includes:
To satisfactorily complete the Psychopharmacology Pearls and receive 5 hours of BCPP Recertification and ACPE credit, candidates must meet the following requirements:
You will proceed through the following steps to satisfactorily complete this course:
Your ACPE credit will be submitted directly to CPE Monitor within 48 hours of completion of the examination with a score of 70% or greater (and an evaluation form) as long as you have provided the relevant information in your profile. BCPP Recertification credit is earned and reported for the calendar year in which the examination is successfully completed (2018 or 2019). If you complete the examination in 2018, you will be notified of your BCPP Recertification credit status and any credit will be reported to BPS by January 31, 2019. If you complete the examination in 2019, you will be notified of your BCPP Recertification credit status within 4 weeks of the closing of the activity when the credit is reported to BPS. All participants will gain access to their final grade and the exam results once the final 2019 results are provided to BPS.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Monica Mathys, PharmD, BCPP, CGP
Sandra Mullen, PharmD, BPCP
Jason Noel, PharmD, BCPP
Carol Ott, PharmD, BCPP
Pharmacologic Management of Behavioral and Psychological Symptoms of Major Neurocognitive Disorder
Recognition and Treatment of Mood Dysregulation in Adults with Intellectual Disability
Treatment of Anxiety Disorders in Patients with Co-morbid Bipolar Disorder
Major Depressive Disorder in Children and Adolescents
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Psychopharmacology Pearls product is an application-based program approved for 5 ACPE contact hours. To receive ACPE credit, pharmacists completing this programming are required to complete an evaluation of the course as well as pass an online examination.
Board Certified Psychiatric Pharmacists (BCPPs) may also receive 5 hours of BCPP Recertification Credit for the Psychopharmacology Pearls upon successful completion of an online examination.
CPNP will report credits earned into CPE Monitor after the official exam review and cut-off score determination occurs. ACPE transcripts reflecting CPE Monitor reporting are available at cpnp.org/mycpnp/transcript/acpe. You can access your BCPP Recertification transcript at cpnp.org/bcpp/transcript. This user-friendly transcript provides real-time access to a listing of the BCPP Recertification programming you have successfully completed in your current 7-year cycle along with your BCPP number and links to other BCPP Recertification resources.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
The articles in this learning activity were developed by the authors in conjunction with the planning committee. Each article subsequently was peer-reviewed and copyedited by the Mental Health Clinician (MHC) prior to publication. As a scholarly journal, the MHC utilizes external double-blind peer review such that reviewer details are not presented here. MHC Editorial Board policies are online.
All relevant relationships have been mitigated.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.